Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Developmental delay referrals and the roles of Fragile X testing and molecular karyotyping: a New Zealand perspective.

Molecular medicine reports - 1 May 2013

Doherty Elaine, O'Connor Rachel, Zhang Anna, Lim Christina, Love Jennifer M, Ashton Fern, Claxton Karen, Gregersen Nerine, George Alice M, Love Donald R

Abstract excerpt

Global developmental delay (GDD) affects ~1-3% of children, many of whom will also have intellectual disability (ID). Fragile X is the major genetic cause of GDD with mental retardation (MR) in males, accounting for ~20% of all X-linked MR. As Fragile X has serious genetic implications, the overwhelming majority of developmental delay (DD) cases referred to our laboratory are concerned with the exclusion of a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Chromosome Banding

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Developmental Disabilities

Share to Fragile X Mental Retardation Protein

Share to Fragile X Syndrome

Share to Karyotyping

Share to New Zealand

Share to Referral and Consultation

Source

Identifiers

PMID: 23525284
DOI: 10.3892/mmr.2013.1386

Genes

FMR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Developmental delay referrals and the roles of Fragile X testing and molecular karyotyping: a New Zealand perspective.PMID 23525284Read ↗

Clinical audit of genetic testing and referral patterns for fragile X and associated conditions.Semantic proximity Read ↗

Newborn, carrier, and early childhood screening recommendations for fragile X.Semantic proximity Read ↗

Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.Semantic proximity Read ↗

Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation.Semantic proximity Read ↗

Genetic counseling and testing for FMR1 gene mutations: practice guidelines of the national society of genetic counselors.Semantic proximity Read ↗

Array CGH as a first line diagnostic test in place of karyotyping for postnatal referrals - results from four years’ clinical application for over 8,700 patientsSemantic proximity Read ↗

ACOG committee opinion. No. 338: Screening for fragile X syndrome.Semantic proximity Read ↗

Validation of Fragile X Screening in the Newborn Population Using a Fit-for-Purpose FMR1 PCR Assay System.Semantic proximity Read ↗

Prenatal carrier testing for fragile X: counseling issues and challenges.Semantic proximity Read ↗

Do the data really support ordering fragile X testing as a first-tier test without clinical features?Semantic proximity Read ↗

The fragile X-associated disorders: time to order fragile X DNA testing.Semantic proximity Read ↗

Fragile X mental retardation syndrome: DNA diagnosis and carrier detection in New Zealand families.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.